Nick Smith

Nick Smith has more than 15 years of publishing experience and he has consulted for several publishing groups over the last three years on topics of sales, marketing, distribution, and process. In 2007, Smith accepted the challenge of leading KP Publishing. Prior to that, Smith founded and served as CEO of Montgomery Media International in 2002. This new media company addressed new markets such as internet advertising with innovative design, content, and distribution models. In 1996, Smith was involved in the founding of a thought leadership publishing company in San Francisco, California. As publisher, he established and managed relationships with companies, including Accenture, IBM, Microsoft and Intel. The business model included working with consultants, analysts, academics, Global 2000 executives and leading technology companies. Project focus included: supply chain, customer relationship management, energy and utilities, and the public sector. Starting his career in London, Smith worked on sports- focused consumer publications in partnership with celebrities, including Lord Sebastian Coe and Tony Jacklin.

nsmith@investingnews.com

Articles

Cobalt Demand Forecast

Cobalt does not usually get much attention from investors. Recent news about Tesla’s (NASDAQ:TSLA) and worldwide demand for lithium ion...

September 15th, 2016

Almonty Industries Financials and NI 43-101 Technical Report on Sangdong Mine

Almonty Industries Inc. (“Almonty” or the “Company”) (AII.V) today announced the filing of its unaudited interim consolidated financial statements and...

August 30th, 2016

Biotech M&A – Pfizer Buys Medivation for $14 Billion

Medivation (NASDAQ:MDVN), the biotech company based in San Francisco, has been a takeover target of several companies and today a...

August 22nd, 2016

BioSig Achieves Important Technical Milestone

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, today announced its submission will be...

August 19th, 2016

Lantern Pharma Announces Transaction to Evaluate BioNumerik’s Tavocept®

DALLAS–(EON: Enhanced Online News)–Lantern Pharma, Inc. (Dallas, TX, US) and BioNumerik Pharmaceuticals, Inc. of San Antonio, Texas have entered into...

August 9th, 2016

Palladium Price: The Next Bull Run?

In addition to gold and silver, palladium is also worth a look, given rising demand for the metal in catalytic...

August 4th, 2016

Biotech bulls are running: Celgene, Biogen and More

Biotech stocks have been on their worst run for decades, but there are indications are that the sector is getting...

August 4th, 2016